1 April 2022 false No description of principal activity Taxfiler 2023.10 4567617business:PrivateLimitedCompanyLtd2022-04-012023-03-31 45676172022-03-31 45676172022-04-012023-03-31 4567617business:AuditExempt-NoAccountantsReport2022-04-012023-03-31 4567617business:FilletedAccounts2022-04-012023-03-31 45676172023-03-31 4567617business:Director12022-04-012023-03-31 4567617business:RegisteredOffice2022-04-012023-03-31 45676172022-03-31 4567617core:WithinOneYear2023-03-31 4567617core:WithinOneYear2022-03-31 4567617core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 4567617core:ShareCapitalcore:PreviouslyStatedAmount2022-03-31 4567617core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 4567617core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-03-31 4567617core:PreviouslyStatedAmount2023-03-31 4567617core:PreviouslyStatedAmount2022-03-31 4567617business:SmallEntities2022-04-012023-03-31 4567617countries:EnglandWales2022-04-012023-03-31 4567617core:LandBuildings2022-04-012023-03-31 4567617core:FurnitureFittings2022-04-012023-03-31 4567617core:LandBuildings2022-03-31 4567617core:FurnitureFittings2022-03-31 4567617core:LandBuildings2023-03-31 4567617core:FurnitureFittings2023-03-31 4567617core:AfterOneYear2023-03-31 4567617core:AfterOneYear2022-03-31 45676172021-04-012022-03-31 iso4217:GBP xbrli:pure
Company Registration No. 4567617 (England and Wales)
Cochrane Opportunity Enterprises Limited Unaudited accounts for the year ended 31 March 2023
Cochrane Opportunity Enterprises Limited Unaudited accounts Contents
Page
- 2 -
Cochrane Opportunity Enterprises Limited Company Information for the year ended 31 March 2023
Director
Lyndsay Margaret Cochrane
Company Number
4567617 (England and Wales)
Registered Office
5 Commercial Street Ystradgynlais Swansea SA9 1HD United Kingdom
Accountants
RGS Accountants Limited 5 Commercial Street Ystradgynlais Swansea SA9 1HD
- 3 -
Cochrane Opportunity Enterprises Limited Statement of financial position as at 31 March 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
480,610 
685,172 
Current assets
Debtors
299,837 
403,399 
Cash at bank and in hand
793,926 
470,774 
1,093,763 
874,173 
Creditors: amounts falling due within one year
(9,206)
(25,608)
Net current assets
1,084,557 
848,565 
Net assets
1,565,167 
1,533,737 
Capital and reserves
Called up share capital
2 
2 
Profit and loss account
1,565,165 
1,533,735 
Shareholders' funds
1,565,167 
1,533,737 
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 7 July 2023 and were signed on its behalf by
Lyndsay Margaret Cochrane Director Company Registration No. 4567617
- 4 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2023
1
Statutory information
Cochrane Opportunity Enterprises Limited is a private company, limited by shares, registered in England and Wales, registration number 4567617. The registered office is 5 Commercial Street, Ystradgynlais, Swansea, SA9 1HD, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
NIL
Fixtures & fittings
Reducing balance: 25% per annum
4
Tangible fixed assets
Land & buildings 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2022
667,699 
100,869 
768,568 
Disposals
(200,194)
- 
(200,194)
At 31 March 2023
467,505 
100,869 
568,374 
Depreciation
At 1 April 2022
- 
83,396 
83,396 
Charge for the year
- 
4,368 
4,368 
At 31 March 2023
- 
87,764 
87,764 
Net book value
At 31 March 2023
467,505 
13,105 
480,610 
At 31 March 2022
667,699 
17,473 
685,172 
- 5 -
Cochrane Opportunity Enterprises Limited Notes to the Accounts for the year ended 31 March 2023
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Other debtors
55,644 
55,644 
Amounts falling due after more than one year
Other debtors
244,193 
347,755 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Taxes and social security
6,806 
5,101 
Other creditors
2,400 
2,000 
Loans from directors
- 
18,507 
9,206 
25,608 
7
Average number of employees
During the year the average number of employees was 0 (2022: 0).
- 6 -